Publications by authors named "Maria Jose Martinez Membrive"
Lung Ultrasound in the Acute Phase of ST-Segment-Elevation Acute Myocardial Infarction: 1-Year Prognosis and Improvement in Risk Prediction.
J Am Heart Assoc
November 2024
Background: Lung ultrasound (LUS) has emerged as a useful tool in the acute phase of patients admitted for ST-segment-elevation myocardial infarction. However, its long-term significance remains uncertain, and risk scores do not include LUS findings as a predictor. This study aims to assess the 1-year prognostic value of LUS and its ability to enhance existing risk scores.
View Article and Find Full Text PDFAims: The Killip scale remains a fundamental tool for prognostic assessment in ST-segment elevation myocardial infarction (STEMI) due to its simplicity and predictive value. Lung ultrasound (LUS) has emerged as a valuable adjunct for diagnosing and predicting outcomes in heart failure (HF) and STEMI patients, even those with subclinical congestion. We created a new classification (Killip pLUS), which reclassifies Killip I and II patients into an intermediate category (Killip I pLUS) based on LUS results.
View Article and Find Full Text PDFArticle Synopsis
- Atrial fibrillation (AF) commonly complicates ST elevation myocardial infarction (STEMI), increasing the risks of heart failure and mortality, making treatment strategies controversial.
- A study analyzed 4,184 STEMI patients, finding that 6.4% developed AF in the first 48 hours, leading to a comparison between AF-STEMI patients and a matched control group.
- Results showed that AF-STEMI patients had worse outcomes, including higher in-hospital mortality (11.9% vs 7.2%) and greater 10-year mortality (50.5% vs 36.2%), alongside a higher recurrence of AF, but no significant difference in stroke rates.